Target intelligence / Profile preview

DNA methylation pathway

Molecular classification
Epigenetic modification, Enzyme-mediated process (involving DNA methyltransferases), Chromatin modification, Other (not a single molecule, but a biochemical pathway)
01

Overview

The **DNA methylation pathway** is an essential epigenetic mechanism involving the covalent addition of a methyl group to the 5-position of cytosine residues within CpG dinucleotides. This process is catalyzed by a family of enzymes known as **DNA methyltransferases**—primarily DNMT1, DNMT3A, and DNMT3B—which regulate both maintenance and de novo establishment of these marks during cell division and development. Methylated cytosines can alter chromatin structure directly or indirectly by recruiting proteins that recognize these modifications (“readers” such as MBD proteins), leading to transcriptional repression or activation depending on context. The patterning established by this pathway plays critical roles in regulating gene expression programs during embryogenesis, cellular differentiation, X-chromosome inactivation, genomic imprinting, aging processes, neurogenesis, immune function regulation—and is frequently dysregulated in human disease. Aberrant activity within the DNA methylation pathway contributes significantly to carcinogenesis through inappropriate silencing of tumor suppressor genes via promoter hypermethylation or genome-wide hypomethylation resulting in chromosomal instability. As such it has become both a **therapeutic target**—with drugs like azacitidine/decitabine approved for certain hematologic malignancies—and an important source for diagnostic/prognostic biomarkers across multiple disease areas including solid tumors and neurological disorders. However—as this entry refers not to a single molecular entity but rather an entire enzymatic/epigenetic process—it should be noted that “DNA methylation pathway” does not correspond precisely to one canonical druggable target but rather encompasses several related molecular targets within its network.[2][3][6][8]

Other names
DNA methylationEpigenetic methylation pathwayCpG methylation pathway
02

Mechanism of action

– Inhibition of DNA methyltransferase enzymes to reduce or reverse abnormal gene silencing by demethylating tumor suppressor genes or other regulatory elements[5]

03

Biological functions

Regulation of gene expressionChromatin organization and remodelingGenomic imprintingCell differentiation and developmentMaintenance of genomic stabilityX-chromosome inactivation (in mammals)
04

Disease associations

Cancer (including gastric, bladder, leukemia, brain tumors)Neurodevelopmental disorders and neurodegenerative diseasesImprinting disordersAging-related diseasesOther epigenetically driven conditions
05

Safety considerations

Off-target effects leading to global hypomethylation and potential activation of oncogenes or repetitive elementsMyelosuppression with DNMT inhibitorsPotential long-term epigenetic instability
06

Interacting drugs

Azacitidine (Vidaza)

3 more in the full profile.

07

Biomarkers

Methylated gene panels for cancer diagnosis/prognosis (e.g., MGMT promoter methylation in gliomas/angiosarcoma for temozolomide response prediction)Circulating cell-free DNA methylation patterns as non-invasive biomarkers for early detection and monitoring in cancers such as gastric cancer

Beyond the preview

Go deeper on DNA methylation pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA methylation pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call